European Commission logo
English English
CORDIS - EU research results
CORDIS

Late Clinical Development of KH176: an innovative orphan drug to reach mitochondrial disease patients & market

Deliverables

Publications

Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A>G heteroplasmy in iPSC-derived neurons

Author(s): Teun M. Klein Gunnewiek Anouk H.A. Verboven Iris Pelgrim Mark Hogeweg Chantal Schoenmaker Herma Renkema Julien Beyrath Jan Smeitink Bert B.A. de Vries Peter-Bram A.C. ’t Hoen Tamas Kozicz Nael Nadif Kasri
Published in: ISSCR, Issue Volume 16, Issue 9, 2021, Page(s) 2197-2212, ISSN 0020-0255
Publisher: Elsevier BV
DOI: 10.1016/j.stemcr.2021.07.002

Intellectual Property Rights

CHROMANYL DERIVATIVES FOR TREATING MITOCHONDRIAL DISEASE

Application/Publication number: 13 759838
Date: 2013-07-12
Applicant(s): KHONDRION BV

CHROMANYL DERIVATIVES FOR TREATING MITOCHONDRIAL DISEASE

Application/Publication number: 13 759838
Date: 2013-07-12
Applicant(s): KHONDRION BV

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available